Centocor Joins Johnson & Johnson, 1999

Image courtesy: Johnson & Johnson Archives

Centocor, one of the first American biotechnology companies, was acquired by Johnson & Johnson. When biotech became the next frontier in science, Johnson & Johnson made strategic acquisitions in the field to expand its research and drug production capacity. Centocor manufactured a range of biopharmaceutical products and diagnostic systems, including REMICADE^®, a medication that treats rheumatoid arthritis and autoimmune disorders, like Crohn’s disease. Today, REMICADE^® remains one of the best-selling biotech medications ever produced.